- Home
- OABI vs VOR Comparison
OABI vs VOR Comparison
Compare OABI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- VOR
- Stock Information
- Founded
- OABI 2012
- VOR 2015
- Country
- OABI United States
- VOR United States
- Employees
- OABI N/A
- VOR N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- OABI Health Care
- VOR Health Care
- Exchange
- OABI Nasdaq
- VOR Nasdaq
- Market Cap
- OABI 228.9M
- VOR 261.0M
- IPO Year
- OABI N/A
- VOR 2021
- Fundamental
- Price
- OABI $1.61
- VOR $27.24
- Analyst Decision
- OABI Strong Buy
- VOR Buy
- Analyst Count
- OABI 3
- VOR 6
- Target Price
- OABI $6.67
- VOR $78.00
- AVG Volume (30 Days)
- OABI 488.9K
- VOR 259.1K
- Earning Date
- OABI 11-11-2025
- VOR 11-06-2025
- Dividend Yield
- OABI N/A
- VOR N/A
- EPS Growth
- OABI N/A
- VOR N/A
- EPS
- OABI N/A
- VOR N/A
- Revenue
- OABI $23,027,000.00
- VOR N/A
- Revenue This Year
- OABI N/A
- VOR N/A
- Revenue Next Year
- OABI $44.99
- VOR N/A
- P/E Ratio
- OABI N/A
- VOR N/A
- Revenue Growth
- OABI 6.05
- VOR N/A
- 52 Week Low
- OABI $1.22
- VOR $2.62
- 52 Week High
- OABI $4.87
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- OABI 43.00
- VOR 27.07
- Support Level
- OABI $1.54
- VOR $36.00
- Resistance Level
- OABI $1.71
- VOR $32.80
- Average True Range (ATR)
- OABI 0.09
- VOR 2.85
- MACD
- OABI 0.01
- VOR -1.25
- Stochastic Oscillator
- OABI 46.51
- VOR 10.95
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.